Provider
P34-16 New Drug-Related Prior Authorization Criteria for Hyperpolarization-Activated Cyclic Nucleotide-Gated (HCN) Channel Blocker Prior Authorization with Quantity Limit Program
Program effective Date: Jul 27, 2016
Program effective Date: Jul 27, 2016
Program effective Date: Oct 10, 2016
Program effective Date: Nov 01, 2018
Program effective Date: Dec 03, 2018
Program effective Date: Dec 03, 2018
Program effective Date: Oct 01, 2018
Program effective Date: Dec 03, 2018
Program effective Date: Nov 01, 2018
Program effective Date: Dec 03, 2018
Program effective Date: Dec 03, 2018